- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/18 - Sulfonamides
Patent holdings for IPC class A61K 31/18
Total number of patents in this class: 2492
10-year publication summary
142
|
159
|
173
|
163
|
173
|
181
|
151
|
175
|
171
|
87
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Cardioxyl Pharmaceuticals, Inc. | 49 |
29 |
Dompé Farmaceutici S.p.A. | 269 |
29 |
The Regents of the University of California | 19929 |
21 |
Board of Regents, The University of Texas System | 5803 |
18 |
AltaThera Pharmaceuticals LLC | 27 |
18 |
Novartis AG | 10850 |
17 |
Baylor College of Medicine | 949 |
17 |
Icahn School of Medicine at Mount Sinai | 949 |
17 |
Remedy Pharmaceuticals, Inc. | 48 |
17 |
F. Hoffmann-La Roche AG | 7921 |
16 |
Centre National de La Recherche Scientifique | 10432 |
16 |
Tvardi Therapeutics, Inc. | 31 |
16 |
Abbvie Inc. | 1801 |
15 |
Purdue Research Foundation | 3615 |
15 |
Bayer Pharma AG | 1047 |
14 |
PIMCO 2664 Limited | 20 |
14 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3156 |
14 |
The Johns Hopkins University | 5669 |
13 |
Boehringer Ingelheim International GmbH | 4648 |
12 |
ChemoCentryx, Inc. | 385 |
12 |
Other owners | 2152 |